Jazz Pharmaceuticals prices upsized $1.1B notes offer
Jazz Pharmaceuticals priced an upsized $1.1 billion private offering of 1.875% exchangeable senior notes due 2032. It will repurchase ordinary shares concurrently.
Story updates
04:37:46 AM UTC
SquawkNews
Jazz Pharmaceuticals Offers Notes in Private Offering to Qualified Institutional Buyers >JAZZ
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.